This site is intended for healthcare professionals only
LoginRegister
MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB PatientsMSN Labs Gets SEC Go-Ahead to Conduct Phase IV Clinical Trial on Elagolix for Endometriosis
Ex-CBIC Officer Nabbed in Rs 27 Crore Hydroponic Marijuana Racket Busted by Delhi PoliceEx-CBIC Officer Nabbed in Rs 27 Crore Hydroponic Marijuana Racket Busted by Delhi Police
Strides Pharma Science Singapore arm, Kenox Pharma partner to develop multiple nasal spray products for USStrides Pharma Science net profit rises 82 percent at Rs 131.5 crore in Q2
JnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitisJnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitis
Dr Reddys Labs ropes in Srinivas Mallavarapu as Head, Global Portfolio and Head, Business Development, North America.Dr Reddy's Labs ropes in Srinivas Mallavarapu as Head, Global Portfolio and Head, Business...
MSN Labs appoints Kalakuntla Srinivas Rao as Executive Vice President - Formulations Manufacturing OperationsMSN Labs appoints Kalakuntla Srinivas Rao as Executive Vice President - Formulations Manufacturing...
Health Ministry Revises BA/BE Study Rules: Minimum Sample Size Set at 18Health Ministry Drafts Rule to Debar Pharma Applicants Submitting Fake or Misleading Documents
CDSCO Panel Seeks Anesthesiology Expert Review for AIIMS Raipur Trial on Gabapentin, Melatonin, Clonidine FDCCDSCO Panel Seeks Anesthesiology Expert Review for AIIMS Raipur Trial on Gabapentin, Melatonin,...
Boehringer Ingelheim, CDR-Life enter into new agreement to develop autoimmune disease moleculeBoehringer Ingelheim acquires license from Kyowa Kirin to develop autoimmune diseases treatment
Sanofi India net profit falls 7.9 percent in Q2Sanofi India net profit falls 7.9 percent in Q2
Merck, Eisai to shut down late stage trial of liver cancer therapyMerck, Eisai to shut down late stage trial of liver cancer therapy
GSK pulmonary neuroendocrine carcinoma treatment gets Orphan Drug Designation in EUGSK pulmonary neuroendocrine carcinoma treatment gets Orphan Drug Designation in EU
X